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Taste perception is controlled by taste cells that are present in the tongue that produce and
secrete various metabolic hormones. Recent studies have demonstrated that taste recep-
tors in tongue, gut, and pancreas are associated with local hormone secretion. The aim of
this study was to determine whether there is a link between taste sensitivity and levels
of circulating metabolic hormones in humans and whether taste sensitivity is potentially
related to peripheral metabolic regulation. Thirty-one subjects were recruited and sepa-
rated into tasters and non-tasters based on their phenol thiocarbamide (PTC) bitter taste
test results. Fasting plasma and saliva were collected and levels of hormones and cytokines
were assayed. We observed significant differences in both hormone levels and hormone-
body mass index (BMI) correlation between tasters and non-tasters. Tasters had higher
plasma levels of leptin (p=0.05), tumor necrosis factor-α (TNF-α) (p=0.04), and insulin-like
growth factor 1 (IGF-1) (p=0.03). There was also a trend toward increased IGF-1 levels
in the saliva of tasters (p=0.06). We found a positive correlation between plasma levels
of glucose and BMI (R=0.4999, p=0.04) exclusively in non-tasters. In contrast, plasma
C-peptide levels were found to be positively correlated to BMI (R =0.5563, p=0.03) in
tasters. Saliva TNF-α levels were negatively correlated with BMI in tasters (R =−0.5908,
p=0.03). Our findings demonstrate that there are differences in circulating levels of leptin,
TNF-α, and IGF-1 between tasters and non-tasters. These findings indicate that in addition
to the regulation of food consumption, taste perception also appears to be tightly linked to
circulating metabolic hormone levels. People with different taste sensitivity may respond
differently to the nutrient stimulation. Further work investigating the link between taste
perception and peripheral metabolic control could potentially lead to the development of
novel therapies for obesity or Type 2 diabetes.
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INTRODUCTION
The sense of taste is critical for humans to detect nutritionally rele-
vant and harmful compounds in food (1). Human taste sensations
are mainly categorized as: sweet, sour, salty, bitter, and umami. In
addition to the tongue, taste receptors are also present in multiple
peripheral organs including gut, pancreas and also the brain (2).
Studies have shown that in the gut, the secretion of satiation pep-
tides (GLP-1 and PYY) is regulated by the type 1 taste receptor
T1R2/T1R3 heterodimers (3, 4), whereas in the pancreatic β-
cells, the T1R1/T1R3 heterodimers regulate autophagy and insulin
secretion (2, 5). In taste cells, hormones such as PYY, glucagon,
and GLP-1 have also been reported to be present specifically in
T1R3-positive cell types, indicating a close relationship between
these hormones and taste sensitivity (6–9). These metabolic and
appetite hormones regulate taste responsiveness in a paracrine
manner and thus can regulate food intake behavior. Therefore,
taste perception and taste receptor expression are associated with
metabolic and appetite hormones and may regulate peripheral
metabolic control (10, 11).
TNF-α is highly expressed in type 2 taste cells and is co-localized
with the T1R3 receptor subunit (12, 13). TNF-α mRNA has been
shown to be fivefold higher in the taste epithelium than in the non-
taste epithelium in mouse. Such high abundance suggests that it
regulates local immune response and taste sensation (12). On the
other hand, TNF-α that is expressed in adipose tissue also plays
a role in regulating insulin sensitivity in obesity-induced insulin
resistance and type 2 diabetes (14). However, thus far, little has
been reported on TNF-α levels in people who have different taste
sensitivity.
Growth hormones in both brain and peripheral organs reg-
ulate food intake, nutrient absorption, and energy metabolism
(15–17). Many of these hormones and their receptors are found in
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the tongue and saliva, including insulin-like growth factor 1 (IGF-
1) and brain-derived neurotrophic factor (BDNF) (18, 19). The
presence of BDNF and its receptor TrkB in the tongue are nec-
essary for taste bud formation during development (20). IGF-1
is also present in taste cells, together with insulin receptors, IGF-
2 and IGFBP (insulin-like growth factor binding protein). Their
presence might also be associated with cell growth in papilla (19).
Presence of the taste receptors in the gastrointestinal system and
their relationship with gut hormone secretion suggest that there
is a close connection between taste perception and food digestion
and absorption (21, 22). Similarly to the tongue, the taste recep-
tors T1R2 and T1R3 are co-localized with multiple gut hormones
in the intestine (3). Lack of T1R3 or its downstream G protein
α-gustducin results in decreased glucose stimulated GLP-1 secre-
tion (23). The mRNA levels of the T1R2 receptor decrease during
hyperglycemia in healthy human subjects but increase under the
same condition in type 2 diabetic patients, potentially resulting in
increased glucose absorption in these patients (24). In addition,
T1R2, T1R3, and their downstream signaling molecules are also
expressed in pancreatic β-cells and MIN6 insulinoma cells. These
receptors regulate insulin secretion from the MIN6 cells by activat-
ing calcium and cAMP signaling pathway (5). However, whether
there is a difference in hormone levels amongst people who have
differences in taste sensitivity is not clear. The aim of this study was
to determine whether there is a link between taste sensitivity and
levels of circulating hormones in human subjects. We found differ-
ences in levels of plasma leptin, TNF-α, and IGF-1 between tasters
and non-tasters. Our study revealed the associations between taste
perception and hormone levels in both plasma and saliva. These
findings provide a foundation for future studies to further describe
the metabolic differences between the two taste groups.
MATERIALS AND METHODS
SUBJECTS
This study was approved by the institutional review boards of
the National Institute on Aging (Baltimore, MD, USA) and the
Onze Lieve Vrouwe Gasthuis (Amsterdam, The Netherlands),
and all participants gave written informed consent prior to each
assessment. Thirty-one non-diabetic healthy male subjects were
recruited and their medical history and background information
were collected. To avoid any possible influences that could lead
to hormone level and taste perception changes, we introduced a
series of inclusion and exclusion criteria when recruiting subjects
(Table 1). Subjects were given a standardized PTC test, during
which a piece of paper strip impregnated with 0.3 mg/pc PTC was
provided. The subjects were asked to put the strip on their tongue
allowing it to moisten. Subjects who reported a bitter taste, were
classified as“tasters”and subjects who didn’t perceive the bitterness
were classified as “non-tasters” (25). Subjects’ height, weight, and
waist circumference were measured and body mass index (BMI)
was calculated as weight (kg)/[height (m)]2.
MEASUREMENT OF CIRCULATORY AND SALIVA HORMONES
Plasma and saliva samples were collected in the morning after
an overnight fast. For saliva collection, we used Sarstedt salivette
(Sarstedt, Germany) according to the manufacturer’s instructions.
Table 1 | Subject recruiting criteria.
Inclusion criteria Exclusion criteria
Male Age below 30 years or over 55 years
Caucasian BMI lower than 18.5 kg/m2 or higher than 31 kg/m2
Age between 30–55 Psychiatric morbidity (eating disorder, depression,
alcoholism)
Co-morbidity (cardiovascular disease, thyroid
disease, diabetes, obesity)
Previous history of cancer
Use of regular anti-inflammatory medication
Consumption of diets or supplements high in
phytoestrogens
Smoking
BMI, body mass index, calculated as weight (kg)/[height (m)]2.
Briefly, after a subject chewed on a swab for 45 s the swab was
placed into a tube and the saliva sample was obtained by centrifug-
ing at 2000 rpm (4°C) for 10 min. Blood was collected in standard
EDTA-containing sampling tubes, then centrifuged at 3000 rpm,
4°C for 30 mins. Samples were then stored at −80°C until further
processing. Levels of amylin (total), C-peptide, glucose-dependent
insulinotropic peptide (GIP), insulin, TNF-α, leptin, PP, and PYY
were measured using the MILLIPLEX MAP human metabolic hor-
mone magnetic bead panel (EMD Millipore Corporation, Biller-
ica, MA, USA): intra-assay variation was 2–8% (26). Adiponectin
levels were measured using a Millipore ELISA kit, the intra-assay
variation was 1.0–7.4%. BDNF and IL-6 were assayed using R&D
system ELISA kits (Minneapolis, MN, USA): intra-assay variations
were 3.8–6.2 and 1.6–4.2%. IGF-1 was measured by ELISA assay
(Alpco Diagnostics, Salem, NH, USA): intra-assay variation was
5.08–6.65%. Blood glucose levels were measured using a glucose
assay kit (Cayman Chemical Company, Ann Arbor, MI, USA):
intra-assay variation was 4.6–8.1%. All hormone and glucose lev-
els were derived by interpolation from reference curves generated
in the same assays with reference standards of known concentra-
tions. HOMA-IR was calculated using glucose (mg/dL)× insulin
(mU/L)/405(16, 26).
MEASUREMENT OF PLASMA FREE FATTY ACIDS AND
TRIACYLGLYCEROL
Free fatty acid and triacylglycerol levels were measured using
enzymatic assay kits according to the manufacturer’s instructions
(Wako Pure Chemical Industries, Ltd., Japan). Free fatty acid and
triacylglycerol levels were derived by interpolation from reference
curves generated in the same assays with reference standards of
known concentrations (26).
STATISTICAL ANALYSIS
For hormone, lipid, and glucose level measurements, data were
log-transformed to achieve normal distributions for all analy-
ses, and then unpaired t -tests were performed using GraphPad
Prism V5, in which p< 0.05 was considered statistically signifi-
cant. Spearman correlation coefficients were calculated to test the
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correlation between hormone levels and BMI. A value of p< 0.05
was considered statistically significant with respect to the linear
correlations’ deviation from a zero slope.
RESULTS
PLASMA HORMONE, CYTOKINE LEVELS, AND LIPID PROFILE IN
TASTERS AND NON-TASTERS
After dividing our 31 male subjects into tasters and non-tasters, no
significant differences in age, BMI or waist circumference between
the two groups were observed (Table 2). Plasma levels of meta-
bolic hormones are shown in Figure 1, we found that the plasma
IGF-1 levels of tasters were significantly higher than those of non-
tasters (Figure 1A). Glucose, insulin, C-peptide, HOMA-IR, and
adiponectin levels were not different between tasters and non-
tasters (Figures 1B–F). We observed higher plasma leptin levels
in tasters than in non-tasters (Figure 2A, p= 0.05). No differ-
ences in the levels of total amylin, GIP, PP, or PYY were found
(Figures 2B–E). The plasma TNF-α levels in tasters were higher
than in non-tasters (Figure 3A). For IL-6 and BDNF, no differ-
ences were found between tasters and non-tasters (Figures 3B,C).
In addition, free fatty acid and triacylglycerol levels were mea-
sured. No differences were found considering these two lipid levels
(Figure S1 in Supplementary Material).
Table 2 | Subject characteristics.
Factors Tasters Non-tasters
Age (years) 45.8±1.86 40.8±1.93
BMI (kg/m2) 24.7±0.53 25.3±0.56
Waist circumference (cm) 89.6±1.51 89.2±1.71
Data are shown as mean±SEM.
SALIVA HORMONE AND CYTOKINE LEVELS IN TASTERS AND
NON-TASTERS
A trend toward increased IGF-1 was found in tasters compared
with non-tasters (Figure 4A), which was similar to what we
observed in the plasma samples. No differences were found in
the levels of insulin, adiponectin, amylin, TNF-α, IL-6, or BDNF
(Figures 4B–G).
CORRELATIONS BETWEEN PLASMA AND SALIVA HORMONE LEVELS
AND BMI
It is not clear whether BMI association with the hormones
is taste-sensitivity dependent. Spearman’s correlation coefficient
using individual hormone levels versus the BMI revealed a pos-
itive correlation between glucose levels and BMI in non-tasters
(Figure 5A, p= 0.04, R-0.4999) but not in tasters (Figure 5B,
p= 0.14,R= 0.4328). Additionally, a positive correlation between
plasma C-peptide and BMI was found in tasters (Figure 5D,
p= 0.03, R= 0.5563) but not in non-tasters (Figure 5C, p= 0.16,
R= 0.3537). We found a significant negative correlation between
saliva TNF-α levels and BMI (Figure 5F, p= 0.02, R=−0.5908)
in tasters, whereas in non-tasters no correlation was observed
(Figure 5E, p= 0.56, R=−0.1592).
DISCUSSION
Our study of hormones as well as cytokines in plasma and saliva
samples of tasters and non-tasters showed differences in levels
of plasma IGF-1, leptin, and TNF-α. Specifically, higher levels of
all three factors were observed in tasters than in non-tasters. A
positive correlation between plasma glucose levels and BMI was
observed in non-tasters, whereas a positive correlation between
C-peptide and BMI was observed in tasters. Interestingly, a neg-
ative correlation between saliva TNF-α and BMI was observed in
tasters.
FIGURE 1 | Plasma metabolic hormones of non-tasters and tasters.
Plasma samples from non-tasters and tasters were assayed to measure
the levels of IGF-1 (A), glucose (B), insulin (C), C-peptide (D), HOMA-IR
(E), and Adiponectin (F). Results were log-transformed and subjected to a
non-paired two-tailed t -test. A value of p<0.05 was considered
statistically significant.
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FIGURE 2 | Plasma appetite hormones. Appetite hormones including leptin (A), amylin (total) (B), GIP (C), PP (D), and PYY (E) were measured. Results were
log-transformed and subjected to a non-paired two-tailed t -test. A value of p<0.05 was considered statistically significant.
FIGURE 3 | Plasma levels of inflammatory and growth factors. The inflammatory factors TNF-α (A), IL-6 (B), and brain-derived neurotrophic factor BDNF
(C) were measured. Results were log-transformed and subjected to a non-paired two-tailed t -test. A value of p< 0.05 was considered statistically significant.
A well-established method classifying tasters and non-tasters
by assessing the sensitivity to the bitter chemical phenylthiocar-
bamide (PTC) is widely used in both research and food industrial
fields (27–29). Due to its high sensitivity, in the current study,
we chose PTC taste to classify our subjects into tasters and non-
tasters. Studies show that the bitter taste threshold in young
adults is correlated with the thresholds of sucrose, sodium chlo-
ride, quinine-HCl, and monosodium glutamate perceptions (29,
30). Despite the taste receptor differences, bitter and sweet taste
transductions share the same downstream G protein signaling
pathway (31).
Recent studies have reported the presence of hormones reg-
ulating food intake and energy metabolism in oral tissues (6,
32–34). In our study, we found higher circulating levels of lep-
tin in the tasters. The function of leptin has been well demon-
strated as a controller of food intake, energy expenditure, and
body weight (35, 36). In the hypothalamus, injection of leptin
inhibits food intake by inhibiting the activity of AMP-activated
kinase (AMPK) and by activating acetyl-CoA carboxylase (ACC)
(37). Leptin receptors are also expressed in mouse circumval-
late papilla (38). Non-functional leptin receptor mutant mice
(db/db) display a higher preference for sweet taste than do wild-
type mice and administration of leptin suppresses this sweet
taste sensitivity (38). Although in this pilot study, we did not
measure leptin receptor expression in the taste buds of the sub-
jects, the increased leptin levels suggest that differences in the
control of energy homeostasis could exist between tasters and
non-tasters.
The pro-inflammatory cytokine TNF-α is mainly secreted from
monocytes, macrophages, and adipocytes (39, 40). Adipose tissue
is reported to act as an endocrine organ, sensing and regulating
energy status, and activating signals in other organs to maintain
energy balance (41). TNF-α plays a critical role by regulating fatty
acid uptake, lipogenesis, and lipolysis in adipocytes (41). We found
higher levels of plasma TNF-α in tasters than in non-tasters, but
these higher levels were still within a relatively normal range (42).
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FIGURE 4 | Saliva hormones and cytokines of non-tasters and tasters.
Saliva samples from non-tasters and tasters were assayed to measure the
levels of IGF-1 (A), insulin (B), adiponectin (C), amylin (D), TNF-α (E), IL-6
(F), and BDNF (G). Results were log-transformed and subjected to a
two-tailed t -test. A value of p<0.05 was considered statistically
significant.
Furthermore, saliva TNF-α levels were negatively correlated with
BMI in tasters but not in non-tasters. TNF-α expression in the
type 2 taste cells has been reported to contribute to local immune
surveillance given the observation of rapid increase of TNF-α lev-
els in these taste cells upon inflammation challenge (12). Because
immune cells are rarely found in the taste buds (43), the level
of TNF-α in the saliva to some extent reflects the amount and
function of type 2 taste cells. Therefore, our observation of the
negative correlation between TNF-α and BMI suggests that in
tasters lower BMI could be related to a better taste cell function and
taste perception. Whereas in non-tasters, there is no such relation
exists.
No report to date has conclusively shown whether taste sen-
sitivity in humans is associated with body weight and insulin
sensitivity. In this study, we excluded subjects with metabolic dis-
orders, thus, the levels of glucose, insulin, and C-peptide were not
different between tasters and non-tasters. However, we observed
a positive correlation between plasma glucose and BMI in non-
tasters but not tasters, suggesting that plasma glucose levels are
more affected by body weight in non-tasters than in tasters. Addi-
tionally, the C-peptide levels in tasters were correlated with BMI.
C-peptide is produced from proinsulin in pancreatic β-cells and
links peptides A and B of insulin (44). C-peptide is released
simultaneously with insulin from β-cells and yet has a longer
half-life than insulin. Thus, the plasma C-peptide level is used
as a more reliable indicator of pancreatic β-cell secretion function
(45). We found the C-peptide levels of tasters to be correlated
with BMI, raising the interesting possibility that β-cell secre-
tory function could be more sensitive to body weight changes in
these subjects. Although, both tasters and non-tasters in this study
exhibited normal plasma glucose and insulin levels. The correla-
tion between glucose and BMI in non-tasters and the correlation
between C-peptide and BMI in tasters imply that when consid-
ering the body weight effect on the glucose stimulated insulin
secretion, tasters may have higher sensitivity to blood glucose
change, and stimulate insulin secretion better to cope with the
increased need.
Additionally, we observed increased plasma IGF-1 levels in the
tasters and this same trend was also found in saliva. Studies show
that the association between IGF-1 levels and diabetes risk form
a U-shaped curve, indicating that people with either low or high
levels of IGF-1 possess a higher risk of developing type 2 dia-
betes (46). The role of IGF-1 in the metabolic function of tasters
and non-tasters remains unclear and further studies are needed to
investigate this. In summary, our study of the hormones in peo-
ple with different taste sensitivities suggests a close relationship
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FIGURE 5 | Spearman’s correlation coefficient analysis correlating
plasma and saliva factors and body mass index (BMI). Plasma glucose
levels (A,B) were correlated with BMI in non-tasters but not tasters.
C-peptide was correlated with BMI in tasters but not non-tasters (C,D). Saliva
TNF-α was reversely correlated with BMI in tasters but not non-tasters (E,F).
A value of p< 0.05 was considered statistically significant.
between taste perception and hormone secretion. People with dif-
ferent taste sensitivity may have differences in their response to
the nutrient stimulation and in their metabolic hormone secre-
tion. In general, tasters exhibited higher levels of leptin, TNF-α,
and IGF-1 than non-tasters. Our study also indicates that the
taste perception, in addition to its role of directly control food
consumption, may also affect food absorption, digestion, and
energy metabolism by affecting hormone levels in human. Due
to the limitation of sample size and exclusion of subjects with
metabolic disorders in the current study, we did not observe any
differences in the levels of plasma glucose, insulin, or HOMA-IR.
Recent studies of taste receptors controlling the hormone release
in both the gut and pancreas have set a focus on the impor-
tance of these receptors in the metabolic function of the body.
However, more work still needs to be done to uncover the poten-
tial role of taste perception in human metabolic control and we
hope that our study will encourage further work concerning this
topic.
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